Timothy A Wicks is Director of Pear Therapeutics, Inc.. Currently has a direct ownership of 52,380 shares of PEAR, which is worth approximately $523. The most recent transaction as insider was on Feb 15, 2023, when has been sold 52,380 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.4K
0% 3M change
0% 12M change
Total Value Held $523

Timothy A Wicks Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2023
BUY
Grant, award, or other acquisition
-
52,380 Added 50.0%
52,380 Class A Common Stock

Also insider at

BTSG
BrightSpring Health Services, Inc.
TAW

Timothy A Wicks

Director
Boston, MA

Track Institutional and Insider Activities on PEAR

Follow Pear Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEAR shares.

Notify only if

Insider Trading

Get notified when an Pear Therapeutics, Inc. insider buys or sells PEAR shares.

Notify only if

News

Receive news related to Pear Therapeutics, Inc.

Track Activities on PEAR